Profil
Todd J.
Johnson worked as a Director of Research & Development at Cambrex Corp.
from 2008 to 2010.
He also worked as a Director at Zevra Therapeutics, Inc. from 2007 to 2010.
Prior to that, he was a Senior Director of Development at Metaphore Pharmaceuticals, Inc. and a Vice President of Business Development at Abc Pharma Services.
Johnson holds a doctorate degree from Indiana University and an undergraduate degree from the University of Iowa.
Ehemalige bekannte Positionen von Todd J. Johnson
| Unternehmen | Position | Ende |
|---|---|---|
| CAMBREX CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2010 |
Metaphore Pharmaceuticals, Inc.
 Metaphore Pharmaceuticals, Inc. BiotechnologyHealth Technology Metaphore Pharmaceuticals, Inc. is a pharmaceutical company which discovers, develops and markets drugs that prevent and treat pain, autoimmune disorders and inflammation. The company leverages its expertise in chemistry and biology to discover and develop small molecule compounds that mimic the activity of human enzymes. The company's compounds mimic the function of superoxide dismutase (SOD), a beneficial enzyme that serves an important protective role in the body by removing superoxide, a toxic free radical that can damage cells and tissues. Superoxide anions are implicated in a variety of diseases associated with pain and inflammation. The company is headquartered in St. Louis, MO. | Corporate Officer/Principal | - |
| Abc Pharma Services | Corporate Officer/Principal | - |
| ZEVRA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Todd J. Johnson
| Indiana University | Doctorate Degree |
| University of Iowa | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
Metaphore Pharmaceuticals, Inc.
Metaphore Pharmaceuticals, Inc. BiotechnologyHealth Technology Metaphore Pharmaceuticals, Inc. is a pharmaceutical company which discovers, develops and markets drugs that prevent and treat pain, autoimmune disorders and inflammation. The company leverages its expertise in chemistry and biology to discover and develop small molecule compounds that mimic the activity of human enzymes. The company's compounds mimic the function of superoxide dismutase (SOD), a beneficial enzyme that serves an important protective role in the body by removing superoxide, a toxic free radical that can damage cells and tissues. Superoxide anions are implicated in a variety of diseases associated with pain and inflammation. The company is headquartered in St. Louis, MO. | Health Technology |
| Abc Pharma Services |
